ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print March 15, 2006, 10.1183/09031936.06.00135305
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hegmans, J. P. J. J.
Right arrow Articles by Lambrecht, B. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hegmans, J. P. J. J.
Right arrow Articles by Lambrecht, B. N.
Eur Respir J 2006; 27:1086-1095
Copyright ©ERS Journals Ltd 2006

Mesothelioma environment comprises cytokines and T-regulatory cells that suppress immune responses

J. P. J. J. Hegmans1, A. Hemmes1, H. Hammad1, L. Boon2, H. C. Hoogsteden1 and B. N. Lambrecht1

1 Dept of Pulmonary Medicine, Erasmus MC, Rotterdam, and 2 Bioceros B.V., Utrecht, The Netherlands.

CORRESPONDENCE: J. P. J. J. Hegmans, H-Ee2253a, Dept of Pulmonary Medicine, Erasmus MC, P.O. Box 1738, 3000 DR, Rotterdam, The Netherlands, Fax: 31 104089453. E-mail: j.hegmans{at}erasmus.nl

Keywords: Cancer, Foxp3, immunosuppression, immunotherapy, micro-environment

Received: November 16, 2005
Accepted February 22, 2006

Malignant mesothelioma is a cancer with dismal prognosis. The objective of the present study was to address the role of the immune system, tumour micro-environment and potential immunosuppression in mesothelioma.

Expression profiles of 80 cytokines were determined in the supernatant of mesothelioma cell lines and the original patient's pleural effusion. Influx of immune effector cells was detected by immunohistochemistry.

Angiogenin, vascular endothelial growth factor, transforming growth factor-ß, epithelial neutrophil-activating protein-78 and several other proteins involved in immune suppression, angiogenesis and plasma extravasation could be detected in both supernatant and pleural effusion. Surrounding stroma and/or infiltrating cells were the most likely source of hepatocyte growth factor, macrophage inflammatory protein (MIP)-1{delta}, MIP-3{alpha}, neutrophil-activating peptide-2, and pulmonary and activation-regulated chemokine that can cause leukocyte infiltration and activation. There was a massive influx of CD4+ and CD8+ T-lymphocytes and macrophages, but not of dendritic cells, in human mesothelioma biopsies. It was further demonstrated that human mesothelioma tissue contained significant amounts of Foxp3+CD4+CD25+ regulatory T-cells. When these CD25+ regulatory T-cells were depleted in an in vivo mouse model, survival increased.

Mesothelioma is infiltrated by immune effector cells but also contains cytokines and regulatory T-cells that suppress an efficient immune response. Immunotherapy of mesothelioma might be more effective when combined with drugs that eliminate or control regulatory T-cells.




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Anraku, K. S. Cunningham, Z. Yun, M.-S. Tsao, L. Zhang, S. Keshavjee, M. R. Johnston, and M. de Perrot
Impact of tumor-infiltrating T cells on survival in patients with malignant pleural mesothelioma.
J. Thorac. Cardiovasc. Surg., April 1, 2008; 135(4): 823 - 829.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
N. R. Miselis, Z. J. Wu, N. Van Rooijen, and A. B. Kane
Targeting tumor-associated macrophages in an orthotopic murine model of diffuse malignant mesothelioma
Mol. Cancer Ther., April 1, 2008; 7(4): 788 - 799.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. M. Wagner, J. Sanchez, J. Y. McClintock, J. Jenkins, and A. Moldobaeva
Inflammation and ischemia-induced lung angiogenesis
Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L351 - L357.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the European Respiratory Society.